vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Getty Images Holdings, Inc. (GETY). Click either name above to swap in a different company.
Getty Images Holdings, Inc. is the larger business by last-quarter revenue ($282.3M vs $185.2M, roughly 1.5× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -32.2%, a 33.1% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 14.1%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $7.7M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 12.7%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Getty Images Holdings, Inc. is a visual media company and supplier of stock images, editorial photography, video, and music for businesses and consumers, with a library of over 477 million assets. It targets three markets—creative professionals, the media, and corporate.
FOLD vs GETY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $282.3M |
| Net Profit | $1.7M | $-90.9M |
| Gross Margin | 85.7% | 74.8% |
| Operating Margin | 8.6% | -8.5% |
| Net Margin | 0.9% | -32.2% |
| Revenue YoY | 23.7% | 14.1% |
| Net Profit YoY | -88.5% | -467.6% |
| EPS (diluted) | $0.00 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $282.3M | ||
| Q3 25 | $169.1M | $240.0M | ||
| Q2 25 | $154.7M | $234.9M | ||
| Q1 25 | $125.2M | $224.1M | ||
| Q4 24 | $149.7M | $247.3M | ||
| Q3 24 | $141.5M | $240.5M | ||
| Q2 24 | $126.7M | $229.1M | ||
| Q1 24 | $110.4M | $222.3M |
| Q4 25 | $1.7M | $-90.9M | ||
| Q3 25 | $17.3M | $21.6M | ||
| Q2 25 | $-24.4M | $-34.4M | ||
| Q1 25 | $-21.7M | $-102.6M | ||
| Q4 24 | $14.7M | $24.7M | ||
| Q3 24 | $-6.7M | $-2.5M | ||
| Q2 24 | $-15.7M | $3.7M | ||
| Q1 24 | $-48.4M | $13.6M |
| Q4 25 | 85.7% | 74.8% | ||
| Q3 25 | 88.5% | 73.2% | ||
| Q2 25 | 90.2% | 72.1% | ||
| Q1 25 | 90.7% | 73.1% | ||
| Q4 24 | 90.1% | 73.5% | ||
| Q3 24 | 90.6% | 73.4% | ||
| Q2 24 | 91.1% | 72.5% | ||
| Q1 24 | 87.7% | 72.9% |
| Q4 25 | 8.6% | -8.5% | ||
| Q3 25 | 20.3% | 18.8% | ||
| Q2 25 | -6.1% | 15.1% | ||
| Q1 25 | -6.3% | 12.2% | ||
| Q4 24 | 10.7% | 14.5% | ||
| Q3 24 | 15.3% | 23.9% | ||
| Q2 24 | 11.8% | 20.3% | ||
| Q1 24 | -25.1% | 18.5% |
| Q4 25 | 0.9% | -32.2% | ||
| Q3 25 | 10.2% | 9.0% | ||
| Q2 25 | -15.8% | -14.6% | ||
| Q1 25 | -17.3% | -45.8% | ||
| Q4 24 | 9.8% | 10.0% | ||
| Q3 24 | -4.8% | -1.1% | ||
| Q2 24 | -12.4% | 1.6% | ||
| Q1 24 | -43.9% | 6.1% |
| Q4 25 | $0.00 | $-0.22 | ||
| Q3 25 | $0.06 | $0.05 | ||
| Q2 25 | $-0.08 | $-0.08 | ||
| Q1 25 | $-0.07 | $-0.25 | ||
| Q4 24 | $0.05 | $0.07 | ||
| Q3 24 | $-0.02 | $-0.01 | ||
| Q2 24 | $-0.05 | $0.01 | ||
| Q1 24 | $-0.16 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $90.2M |
| Total DebtLower is stronger | $392.7M | $1.3B |
| Stockholders' EquityBook value | $274.2M | $552.5M |
| Total Assets | $949.9M | $3.2B |
| Debt / EquityLower = less leverage | 1.43× | 2.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $90.2M | ||
| Q3 25 | $263.8M | $109.5M | ||
| Q2 25 | $231.0M | $110.3M | ||
| Q1 25 | $250.6M | $114.6M | ||
| Q4 24 | $249.9M | $121.2M | ||
| Q3 24 | $249.8M | $109.9M | ||
| Q2 24 | $260.1M | $121.7M | ||
| Q1 24 | $239.6M | $134.2M |
| Q4 25 | $392.7M | $1.3B | ||
| Q3 25 | $392.0M | $1.3B | ||
| Q2 25 | $391.3M | $1.3B | ||
| Q1 25 | $390.7M | $1.3B | ||
| Q4 24 | $390.1M | $1.3B | ||
| Q3 24 | $389.5M | $1.3B | ||
| Q2 24 | $388.9M | $1.3B | ||
| Q1 24 | $388.4M | $1.4B |
| Q4 25 | $274.2M | $552.5M | ||
| Q3 25 | $230.4M | $634.6M | ||
| Q2 25 | $204.3M | $611.2M | ||
| Q1 25 | $193.6M | $593.0M | ||
| Q4 24 | $194.0M | $670.2M | ||
| Q3 24 | $178.8M | $683.4M | ||
| Q2 24 | $132.5M | $654.0M | ||
| Q1 24 | $130.7M | $640.8M |
| Q4 25 | $949.9M | $3.2B | ||
| Q3 25 | $868.8M | $2.6B | ||
| Q2 25 | $815.3M | $2.6B | ||
| Q1 25 | $789.8M | $2.6B | ||
| Q4 24 | $785.0M | $2.6B | ||
| Q3 24 | $786.6M | $2.6B | ||
| Q2 24 | $749.5M | $2.6B | ||
| Q1 24 | $721.8M | $2.6B |
| Q4 25 | 1.43× | 2.30× | ||
| Q3 25 | 1.70× | 2.11× | ||
| Q2 25 | 1.92× | 2.19× | ||
| Q1 25 | 2.02× | 2.21× | ||
| Q4 24 | 2.01× | 1.96× | ||
| Q3 24 | 2.18× | 1.97× | ||
| Q2 24 | 2.93× | 2.06× | ||
| Q1 24 | 2.97× | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $20.6M |
| Free Cash FlowOCF − Capex | $16.0M | $7.7M |
| FCF MarginFCF / Revenue | 8.6% | 2.7% |
| Capex IntensityCapex / Revenue | 0.2% | 4.6% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $20.6M | ||
| Q3 25 | $35.7M | $22.6M | ||
| Q2 25 | $-26.5M | $6.5M | ||
| Q1 25 | $7.8M | $15.4M | ||
| Q4 24 | $-3.9M | $39.7M | ||
| Q3 24 | $-23.0M | $10.7M | ||
| Q2 24 | $22.7M | $46.4M | ||
| Q1 24 | $-29.7M | $21.5M |
| Q4 25 | $16.0M | $7.7M | ||
| Q3 25 | $35.3M | $7.9M | ||
| Q2 25 | $-28.9M | $-9.6M | ||
| Q1 25 | $7.5M | $-322.0K | ||
| Q4 24 | $-4.2M | $24.6M | ||
| Q3 24 | $-23.3M | $-1.8M | ||
| Q2 24 | $21.6M | $31.1M | ||
| Q1 24 | $-31.5M | $7.1M |
| Q4 25 | 8.6% | 2.7% | ||
| Q3 25 | 20.9% | 3.3% | ||
| Q2 25 | -18.7% | -4.1% | ||
| Q1 25 | 6.0% | -0.1% | ||
| Q4 24 | -2.8% | 9.9% | ||
| Q3 24 | -16.5% | -0.8% | ||
| Q2 24 | 17.0% | 13.6% | ||
| Q1 24 | -28.5% | 3.2% |
| Q4 25 | 0.2% | 4.6% | ||
| Q3 25 | 0.2% | 6.1% | ||
| Q2 25 | 1.6% | 6.9% | ||
| Q1 25 | 0.2% | 7.0% | ||
| Q4 24 | 0.2% | 6.1% | ||
| Q3 24 | 0.3% | 5.2% | ||
| Q2 24 | 0.9% | 6.7% | ||
| Q1 24 | 1.6% | 6.5% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | 1.05× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | 1.61× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.59× | ||
| Q1 24 | — | 1.58× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
GETY
| Creative | $149.0M | 53% |
| Editorial | $109.4M | 39% |
| Other | $23.9M | 8% |
